Logo image of WNS

WNS HOLDINGS LTD (WNS) Stock Fundamental Analysis

NYSE:WNS - New York Stock Exchange, Inc. - JE00BQC4YW14 - Common Stock - Currency: USD

59.05  -0.11 (-0.19%)

After market: 59.05 0 (0%)

Fundamental Rating

5

Overall WNS gets a fundamental rating of 5 out of 10. We evaluated WNS against 82 industry peers in the IT Services industry. WNS has only an average score on both its financial health and profitability. WNS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

WNS had positive earnings in the past year.
In the past year WNS had a positive cash flow from operations.
WNS had positive earnings in 4 of the past 5 years.
Of the past 5 years WNS 4 years had a positive operating cash flow.
WNS Yearly Net Income VS EBIT VS OCF VS FCFWNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

With a decent Return On Assets value of 9.35%, WNS is doing good in the industry, outperforming 78.05% of the companies in the same industry.
With a decent Return On Equity value of 17.28%, WNS is doing good in the industry, outperforming 79.27% of the companies in the same industry.
WNS has a Return On Invested Capital of 13.34%. This is amongst the best in the industry. WNS outperforms 81.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for WNS is significantly below the industry average of 22.24%.
The last Return On Invested Capital (13.34%) for WNS is above the 3 year average (13.21%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.35%
ROE 17.28%
ROIC 13.34%
ROA(3y)10.13%
ROA(5y)10.24%
ROE(3y)17.65%
ROE(5y)17.57%
ROIC(3y)13.21%
ROIC(5y)13.57%
WNS Yearly ROA, ROE, ROICWNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

WNS's Profit Margin of 10.02% is fine compared to the rest of the industry. WNS outperforms 76.83% of its industry peers.
In the last couple of years the Profit Margin of WNS has declined.
WNS's Operating Margin of 13.48% is fine compared to the rest of the industry. WNS outperforms 76.83% of its industry peers.
WNS's Operating Margin has been stable in the last couple of years.
WNS has a Gross Margin (35.54%) which is in line with its industry peers.
WNS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.48%
PM (TTM) 10.02%
GM 35.54%
OM growth 3Y-2.34%
OM growth 5Y-0.55%
PM growth 3Y-1.98%
PM growth 5Y-4.06%
GM growth 3Y0.46%
GM growth 5Y0.11%
WNS Yearly Profit, Operating, Gross MarginsWNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so WNS is still creating some value.
There is no outstanding debt for WNS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
WNS Yearly Shares OutstandingWNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
WNS Yearly Total Debt VS Total AssetsWNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 5.27 indicates that WNS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.27, WNS is in the better half of the industry, outperforming 76.83% of the companies in the same industry.
WNS has a debt to FCF ratio of 1.14. This is a very positive value and a sign of high solvency as it would only need 1.14 years to pay back of all of its debts.
WNS's Debt to FCF ratio of 1.14 is amongst the best of the industry. WNS outperforms 80.49% of its industry peers.
WNS has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of WNS (0.19) is better than 64.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.14
Altman-Z 5.27
ROIC/WACC1.34
WACC9.98%
WNS Yearly LT Debt VS Equity VS FCFWNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

WNS has a Current Ratio of 1.81. This is a normal value and indicates that WNS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.81, WNS perfoms like the industry average, outperforming 59.76% of the companies in the same industry.
WNS has a Quick Ratio of 1.81. This is a normal value and indicates that WNS is financially healthy and should not expect problems in meeting its short term obligations.
WNS has a Quick ratio of 1.81. This is comparable to the rest of the industry: WNS outperforms 59.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.81
WNS Yearly Current Assets VS Current LiabilitesWNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.41% over the past year.
Measured over the past 5 years, WNS shows a small growth in Earnings Per Share. The EPS has been growing by 7.77% on average per year.
EPS 1Y (TTM)3.41%
EPS 3Y9.66%
EPS 5Y7.77%
EPS Q2Q%29.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.8%

3.2 Future

WNS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.79% yearly.
WNS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.70% yearly.
EPS Next Y3.05%
EPS Next 2Y7.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.06%
Revenue Next 2Y8.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
WNS Yearly Revenue VS EstimatesWNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
WNS Yearly EPS VS EstimatesWNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.98, which indicates a correct valuation of WNS.
Based on the Price/Earnings ratio, WNS is valued cheaper than 84.15% of the companies in the same industry.
When comparing the Price/Earnings ratio of WNS to the average of the S&P500 Index (23.99), we can say WNS is valued slightly cheaper.
With a Price/Forward Earnings ratio of 12.59, WNS is valued correctly.
Based on the Price/Forward Earnings ratio, WNS is valued cheaper than 82.93% of the companies in the same industry.
WNS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.35.
Industry RankSector Rank
PE 12.98
Fwd PE 12.59
WNS Price Earnings VS Forward Price EarningsWNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WNS indicates a somewhat cheap valuation: WNS is cheaper than 79.27% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WNS indicates a rather cheap valuation: WNS is cheaper than 80.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.75
EV/EBITDA 9.77
WNS Per share dataWNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WNS does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of WNS may justify a higher PE ratio.
PEG (NY)4.26
PEG (5Y)1.67
EPS Next 2Y7.79%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

WNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WNS HOLDINGS LTD

NYSE:WNS (5/7/2025, 8:04:00 PM)

After market: 59.05 0 (0%)

59.05

-0.11 (-0.19%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-16 2025-07-16/bmo
Inst Owners90.26%
Inst Owner Change-100%
Ins Owners1.83%
Ins Owner ChangeN/A
Market Cap2.76B
Analysts82.86
Price Target71.11 (20.42%)
Short Float %6.47%
Short Ratio3.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.27%
Min EPS beat(2)-0.85%
Max EPS beat(2)13.39%
EPS beat(4)3
Avg EPS beat(4)4.56%
Min EPS beat(4)-0.85%
Max EPS beat(4)13.39%
EPS beat(8)7
Avg EPS beat(8)6.17%
EPS beat(12)11
Avg EPS beat(12)6.61%
EPS beat(16)15
Avg EPS beat(16)6.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-2.27%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-0.76%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-0.07%
Revenue beat(8)2
Avg Revenue beat(8)0.07%
Revenue beat(12)6
Avg Revenue beat(12)2.63%
Revenue beat(16)10
Avg Revenue beat(16)4.27%
PT rev (1m)7.49%
PT rev (3m)8.69%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)2.45%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)0.67%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 12.98
Fwd PE 12.59
P/S 2.1
P/FCF 15.75
P/OCF 12.48
P/B 3.62
P/tB 9.27
EV/EBITDA 9.77
EPS(TTM)4.55
EY7.71%
EPS(NY)4.69
Fwd EY7.94%
FCF(TTM)3.75
FCFY6.35%
OCF(TTM)4.73
OCFY8.01%
SpS28.1
BVpS16.3
TBVpS6.37
PEG (NY)4.26
PEG (5Y)1.67
Profitability
Industry RankSector Rank
ROA 9.35%
ROE 17.28%
ROCE 15.78%
ROIC 13.34%
ROICexc 16.8%
ROICexgc 35.04%
OM 13.48%
PM (TTM) 10.02%
GM 35.54%
FCFM 13.34%
ROA(3y)10.13%
ROA(5y)10.24%
ROE(3y)17.65%
ROE(5y)17.57%
ROIC(3y)13.21%
ROIC(5y)13.57%
ROICexc(3y)17.84%
ROICexc(5y)18.87%
ROICexgc(3y)33.57%
ROICexgc(5y)32.23%
ROCE(3y)15.81%
ROCE(5y)16.16%
ROICexcg growth 3Y9.06%
ROICexcg growth 5Y-0.2%
ROICexc growth 3Y-3.92%
ROICexc growth 5Y-3.57%
OM growth 3Y-2.34%
OM growth 5Y-0.55%
PM growth 3Y-1.98%
PM growth 5Y-4.06%
GM growth 3Y0.46%
GM growth 5Y0.11%
F-Score6
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.14
Debt/EBITDA 0.54
Cap/Depr 51.22%
Cap/Sales 3.49%
Interest Coverage 9.02
Cash Conversion 82.9%
Profit Quality 133.09%
Current Ratio 1.81
Quick Ratio 1.81
Altman-Z 5.27
F-Score6
WACC9.98%
ROIC/WACC1.34
Cap/Depr(3y)55.82%
Cap/Depr(5y)50.83%
Cap/Sales(3y)3.44%
Cap/Sales(5y)3.25%
Profit Quality(3y)120.61%
Profit Quality(5y)143.24%
High Growth Momentum
Growth
EPS 1Y (TTM)3.41%
EPS 3Y9.66%
EPS 5Y7.77%
EPS Q2Q%29.46%
EPS Next Y3.05%
EPS Next 2Y7.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.8%
Revenue Next Year8.06%
Revenue Next 2Y8.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.59%
EBIT growth 3Y10.54%
EBIT growth 5Y9.74%
EBIT Next Year-1.49%
EBIT Next 3Y5.57%
EBIT Next 5YN/A
FCF growth 1Y9.34%
FCF growth 3Y-2.23%
FCF growth 5Y8.31%
OCF growth 1Y11.84%
OCF growth 3Y2.36%
OCF growth 5Y8.9%